Reuters logo
BRIEF-Sunesis Pharmaceuticals qtrly basic and diluted loss per share $0.47
2017年5月8日 / 上午11点17分 / 7 个月前

BRIEF-Sunesis Pharmaceuticals qtrly basic and diluted loss per share $0.47

May 8 (Reuters) - Sunesis Pharmaceuticals Inc

* Sunesis pharmaceuticals reports first quarter 2017 financial results and recent highlights

* Q1 revenue $700,000 versus $600,000

* Q1 revenue view $1.6 million -- Thomson Reuters I/B/E/S

* Sunesis pharmaceuticals inc qtrly basic and diluted loss per share of $0.47

* Q1 earnings per share view $-0.69 -- Thomson Reuters I/B/E/S

* Sunesis pharmaceuticals inc - expects that its current cash resources are sufficient to fund company into june 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below